The use of gadolinium in the MR evaluation of musculoskeletal tumors

Mark J. Kransdorf

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Magnetic resonance (MR) imaging has emerged as the preferred modality for the imaging evaluation of musculoskeletal tumors. Although there is general agreement on the value of MR in diagnosis and staging, the use of intravenous contrast in the evaluation of musculoskeletal lesions remains controversial. The purpose of this review is to highlight these controversies, to put them in perspective, arid to suggest recommendations for the use of gadopentetate dimeglumine. The following specific areas will be addressed: (a) evaluation of soft-tissue tumors, (b) diagnosis of low-grade chondrosarcoma and the use of contrast material in identification of intraosseous metastases, (c) monitoring response to chemotherapy, (d) evaluation for local recurrence after surgery and/or radiation therapy, and (e) selection of biopsy site.

Original languageEnglish (US)
Pages (from-to)15-23
Number of pages9
JournalTopics in Magnetic Resonance Imaging
Volume8
Issue number1
StatePublished - Feb 1996
Externally publishedYes

Fingerprint

Gadolinium
Magnetic Resonance Spectroscopy
Neoplasms
Gadolinium DTPA
Chondrosarcoma
Contrast Media
Radiotherapy
Magnetic Resonance Imaging
Neoplasm Metastasis
Biopsy
Recurrence
Drug Therapy

Keywords

  • Bone neoplasms
  • Gadolinium
  • Magnetic resonance imaging
  • Musculoskeletal neoplasms
  • Postoperative changes
  • Soft-tissue neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

The use of gadolinium in the MR evaluation of musculoskeletal tumors. / Kransdorf, Mark J.

In: Topics in Magnetic Resonance Imaging, Vol. 8, No. 1, 02.1996, p. 15-23.

Research output: Contribution to journalArticle

@article{2745f4c350924f72bf8dab550db72c3c,
title = "The use of gadolinium in the MR evaluation of musculoskeletal tumors",
abstract = "Magnetic resonance (MR) imaging has emerged as the preferred modality for the imaging evaluation of musculoskeletal tumors. Although there is general agreement on the value of MR in diagnosis and staging, the use of intravenous contrast in the evaluation of musculoskeletal lesions remains controversial. The purpose of this review is to highlight these controversies, to put them in perspective, arid to suggest recommendations for the use of gadopentetate dimeglumine. The following specific areas will be addressed: (a) evaluation of soft-tissue tumors, (b) diagnosis of low-grade chondrosarcoma and the use of contrast material in identification of intraosseous metastases, (c) monitoring response to chemotherapy, (d) evaluation for local recurrence after surgery and/or radiation therapy, and (e) selection of biopsy site.",
keywords = "Bone neoplasms, Gadolinium, Magnetic resonance imaging, Musculoskeletal neoplasms, Postoperative changes, Soft-tissue neoplasms",
author = "Kransdorf, {Mark J.}",
year = "1996",
month = "2",
language = "English (US)",
volume = "8",
pages = "15--23",
journal = "Topics in Magnetic Resonance Imaging",
issn = "0899-3459",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The use of gadolinium in the MR evaluation of musculoskeletal tumors

AU - Kransdorf, Mark J.

PY - 1996/2

Y1 - 1996/2

N2 - Magnetic resonance (MR) imaging has emerged as the preferred modality for the imaging evaluation of musculoskeletal tumors. Although there is general agreement on the value of MR in diagnosis and staging, the use of intravenous contrast in the evaluation of musculoskeletal lesions remains controversial. The purpose of this review is to highlight these controversies, to put them in perspective, arid to suggest recommendations for the use of gadopentetate dimeglumine. The following specific areas will be addressed: (a) evaluation of soft-tissue tumors, (b) diagnosis of low-grade chondrosarcoma and the use of contrast material in identification of intraosseous metastases, (c) monitoring response to chemotherapy, (d) evaluation for local recurrence after surgery and/or radiation therapy, and (e) selection of biopsy site.

AB - Magnetic resonance (MR) imaging has emerged as the preferred modality for the imaging evaluation of musculoskeletal tumors. Although there is general agreement on the value of MR in diagnosis and staging, the use of intravenous contrast in the evaluation of musculoskeletal lesions remains controversial. The purpose of this review is to highlight these controversies, to put them in perspective, arid to suggest recommendations for the use of gadopentetate dimeglumine. The following specific areas will be addressed: (a) evaluation of soft-tissue tumors, (b) diagnosis of low-grade chondrosarcoma and the use of contrast material in identification of intraosseous metastases, (c) monitoring response to chemotherapy, (d) evaluation for local recurrence after surgery and/or radiation therapy, and (e) selection of biopsy site.

KW - Bone neoplasms

KW - Gadolinium

KW - Magnetic resonance imaging

KW - Musculoskeletal neoplasms

KW - Postoperative changes

KW - Soft-tissue neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0030049938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030049938&partnerID=8YFLogxK

M3 - Article

C2 - 8820091

AN - SCOPUS:0030049938

VL - 8

SP - 15

EP - 23

JO - Topics in Magnetic Resonance Imaging

JF - Topics in Magnetic Resonance Imaging

SN - 0899-3459

IS - 1

ER -